GE Healthcare Technologies Inc (GEHC) stock analysis and fair value
GEHC · NASDAQ · Healthcare
70,15 US$
▲ +0,56%
Cerne score
57out of 100
Fair
- Quality66
- Growth29
- Financial strength42
- Valuation81
- Dividends51
In 30 seconds
The business. Healthcare. Sells 20,6 B US$ a year, keeps 10% as profit and sales grow 4,1% a year (last 4 years).
The price. Cheaper than usual: you pay 15x earnings, when its normal is 19x.
Strength. Passes 5 of 8 quality checks, but debt weighs: 3,1 years of profit.
GEHC fair value
Work out what the stock is worth with your own growth, margin and return assumptions. Free during launch.
See the fair valueGE Healthcare Technologies Inc key numbers
- Market cap
- 31,7 B US$
- P/E (price ÷ earnings)
- 15,4
- Dividend yield
- 0,20%
- Revenue growth
- 4,1%
- a year, over 4 years
- Profit margin
- 10,1%
- Quality checks
- 5/8
Fiscal 2025 financials, as filed with the SEC.
What analysts say
Buy
20 of 27 analysts recommend buying.
See everything about GEHC on Cerne
- Fair value with your own assumptions
- Every analyst and price target
- 10 years of financials in simple charts
- Dividends, earnings and ratios vs. the sector